Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-11,449
Closed -$1.98M 52
2020
Q1
$1.98M Sell
11,449
-4,641
-29% -$767K 0.99% 18
2019
Q4
$2.47M Buy
16,090
+559
+4% +$83.5K 0.87% 45
2019
Q3
$2.36M Buy
15,531
+1,219
+9% +$193K 0.87% 50
2019
Q2
$2.19M Sell
14,312
-11,954
-46% -$1.83M 0.84% 59
2019
Q1
$4.21M Buy
26,266
+4,750
+22% +$737K 1.49% 7
2018
Q4
$3.32M Buy
21,516
+2,027
+10% +$316K 1.34% 10
2018
Q3
$2.93M Sell
19,489
-2,033
-9% -$289K 1.2% 15
2018
Q2
$2.91M Buy
21,522
+671
+3% +$82.8K 1.02% 17
2018
Q1
$2.77M Buy
20,851
+2,317
+13% +$311K 1% 14
2017
Q4
$2.75M Buy
18,534
+135
+0.7% +$18.4K 1.04% 15
2017
Q3
$2.43M Sell
18,399
-2,955
-14% -$397K 0.98% 22
2017
Q2
$2.84M Sell
21,354
-24,828
-54% -$3.35M 0.99% 22
2017
Q1
$6.22M Sell
46,182
-15,883
-26% -$2.06M 2.07% 20
2016
Q4
$7.45M Buy
62,065
+58,996
+1,922% +$6.96M 2.27% 19
2016
Q3
$384K Buy
3,069
+76
+3% +$9.95K 0.11% 84
2016
Q2
$414K Sell
2,993
-3,587
-55% -$465K 0.13% 83
2016
Q1
$829K Sell
6,580
-778
-11% -$98.9K 0.31% 73
2015
Q4
$933K Sell
7,358
-32,528
-82% -$4.04M 0.48% 57
2015
Q3
$4.61M Sell
39,886
-2,404
-6% -$270K 2.67% 13
2015
Q2
$4.4M Buy
42,290
+2,379
+6% +$257K 2.52% 19
2015
Q1
$4.41M Buy
+39,911
New +$4.33M 2.59% 11

Other funds holding CLX

Cognios Capital's CLX Position: Q2 2020 in Review

Cognios Capital sold out of Clorox (CLX) in Q2 2020, closing a stake of 11,449 shares — an estimated $1.98M sold.

Cognios Capital first reported a position in CLX in Q1 2015 and held it in 21 quarters. The position peaked at $7.45M in Q4 2016. 1,197 funds tracked by Wall St. Rank hold CLX as of Q2 2020.

  • Cognios Capital reported no remaining Clorox position as of Q2 2020 after selling out during the quarter.
  • Cognios Capital sold 11,449 Clorox shares in Q2 2020, an estimated $1.98M.
  • Cognios Capital first reported a position in Clorox in Q1 2015 and held it in 21 quarters.
  • Cognios Capital's Clorox position peaked at $7.45M in Q4 2016.
  • 1,197 funds tracked by Wall St. Rank held Clorox as of Q2 2020.

Based on Cognios Capital's 13F filing for Q2 2020.